Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
NCT03544723
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Lymphoma
Interventions
DRUG:
Ad-p53
Sponsor
MultiVir, Inc.